Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ketteler

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Kidney International|June 26, 2017
Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it mattersMarkus Ketteler, Geoffrey A Block, Pieter Evenepoel, et al.
Annals of Internal Medicine|February 21, 2018
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline UpdateMarkus Ketteler, Geoffrey A Block, Pieter Evenepoel, et al.
Clinical Kidney Journal|May 22, 2023
Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trialTurgay Saritas, Sebastian Reinartz, Thilo Krüger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2013
Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocolThilo Krueger, Georg Schlieper, Leon Schurgers, et al.
Circulation|November 4, 2005
Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient miceOlivier Phan, Ognen Ivanovski, Thao Nguyen-Khoa, et al.
Kidney International|September 19, 2008
Vascular access calcification predicts mortality in hemodialysis patientsGeorg Schlieper, Thilo Krüger, Zivka Djuric, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2009
Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantationJosef Fangmann, Wolfgang Arns, Hans-Peter Marti, et al.
Clinical Kidney Journal|October 2, 2023
Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patientsDaniela Egli-Spichtig, Ahmad Kamal Hamid, Eva Maria Pastor Arroyo, et al.
Clinical Kidney Journal|December 10, 2025
Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working GroupSharon Huish, Sacha Moore, Carlo Alfieri, et al.
Kidney International|February 5, 2015
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conferenceMarkus Ketteler, Grahame J Elder, Pieter Evenepoel, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Kidney International|June 26, 2017
Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: what's changed and why it mattersMarkus Ketteler, Geoffrey A Block, Pieter Evenepoel, et al.
Annals of Internal Medicine|February 21, 2018
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline UpdateMarkus Ketteler, Geoffrey A Block, Pieter Evenepoel, et al.
Clinical Kidney Journal|May 22, 2023
Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trialTurgay Saritas, Sebastian Reinartz, Thilo Krüger, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 29, 2013
Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocolThilo Krueger, Georg Schlieper, Leon Schurgers, et al.
Circulation|November 4, 2005
Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient miceOlivier Phan, Ognen Ivanovski, Thao Nguyen-Khoa, et al.
Kidney International|September 19, 2008
Vascular access calcification predicts mortality in hemodialysis patientsGeorg Schlieper, Thilo Krüger, Zivka Djuric, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 24, 2009
Impact of daclizumab, low-dose cyclosporine, mycophenolate mofetil and steroids on renal function after kidney transplantationJosef Fangmann, Wolfgang Arns, Hans-Peter Marti, et al.
Clinical Kidney Journal|October 2, 2023
Intact FGF23 predicts serum phosphate improvement after combined nicotinamide and phosphate binder treatment in hemodialysis patientsDaniela Egli-Spichtig, Ahmad Kamal Hamid, Eva Maria Pastor Arroyo, et al.
Clinical Kidney Journal|December 10, 2025
Calciphylaxis diagnosis, management and future directions: a comprehensive update on behalf of the European Renal Association CKD-MBD Working GroupSharon Huish, Sacha Moore, Carlo Alfieri, et al.
Kidney International|February 5, 2015
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conferenceMarkus Ketteler, Grahame J Elder, Pieter Evenepoel, et al.
Pageof 22